ScoreWhy is Nutex Health, Inc. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.18 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 253.30%
3
With a growth in Operating Profit of 46.51%, the company declared Outstanding results in Jun 26
- OPERATING CASH FLOW(Y) Highest at USD 279.62 MM
- ROCE(HY) Highest at 57.16%
- DEBT-EQUITY RATIO (HY) Lowest at 35.56 %
4
With ROE of 54.75%, it has a fair valuation with a 1.98 Price to Book Value
- Over the past year, while the stock has generated a return of 94.70%, its profits have risen by 75.7% ; the PEG ratio of the company is 0.1
5
High Institutional Holdings at 50.97%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 3.7% over the previous quarter.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Nutex Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nutex Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nutex Health, Inc.
103.96%
34.04
94.60%
S&P 500
16.06%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
253.30%
EBIT Growth (5y)
140.41%
EBIT to Interest (avg)
3.68
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
2.46
Tax Ratio
18.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.27%
ROCE (avg)
65.61%
ROE (avg)
55.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.98
EV to EBIT
1.89
EV to EBITDA
1.76
EV to Capital Employed
2.65
EV to Sales
0.59
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
140.59%
ROE (Latest)
54.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 279.62 MM
ROCE(HY)
Highest at 57.16%
DEBT-EQUITY RATIO
(HY)
Lowest at 35.56 %
INTEREST COVERAGE RATIO(Q)
Highest at 2,719.65
PRE-TAX PROFIT(Q)
At USD 117.08 MM has Grown at 87.24%
RAW MATERIAL COST(Y)
Fallen by -31.55% (YoY
CASH AND EQV(HY)
Highest at USD 417.75 MM
OPERATING PROFIT MARGIN(Q)
Highest at 60.28 %
NET PROFIT(Q)
Highest at USD 65.84 MM
EPS(Q)
Highest at USD 9.38
-4What is not working for the Company
NET SALES(9M)
At USD 578.92 MM has Grown at -18.85%
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.38 times
Here's what is working for Nutex Health, Inc.
Net Profit
At USD 65.84 MM has Grown at 173.26%
over average net sales of the previous four periods of USD 24.09 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 279.62 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 2,719.65
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Pre-Tax Profit
At USD 117.08 MM has Grown at 87.24%
over average net sales of the previous four periods of USD 62.53 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Debt-Equity Ratio
Lowest at 35.56 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Profit Margin
Highest at 60.28 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Highest at USD 65.84 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 9.38
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 417.75 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -31.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nutex Health, Inc.
Net Sales
At USD 578.92 MM has Grown at -18.85%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Debtors Turnover Ratio
Lowest at 2.38 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
